Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer - Wikidata - wikimedia - TriplyDB

Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer

Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer

http://www.wikidata.org/entity/Q33986198

about

Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis Role of positron emission tomography for the monitoring of response to therapy in breast cancer Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study Optically measured microvascular blood flow contrast of malignant breast tumors.Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma Delivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancer Oncogene pathway activation in mammary tumors dictates FDG-PET uptake 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.Promise and pitfalls of quantitative imaging in oncology clinical trials.Near-infrared optical mammography for breast cancer detection with intrinsic contrast.Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.Estimating breast tumor blood flow during neoadjuvant chemotherapy using interleaved high temporal and high spatial resolution MRI.Optical imaging of metabolism in HER2 overexpressing breast cancer cells.Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts.Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy.Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.

P2860

Q27003737-31CB699F-1EEA-43E0-AE96-E0FEC61C9504 Q28080621-B87986DE-E043-48D6-A271-3AF248E44910 Q30357444-C12EBCE5-5397-4F7B-83AC-A4584F02C7F3 Q33812407-42409F0C-83FB-4F46-8C5B-4F4A500BBBF9 Q33967878-1B4F5A13-8ACD-4D8F-AB1B-107DE27CEDC2 Q34331734-4EFAD23D-6090-4B2C-8006-205755400E38 Q34410058-CB99F004-8F3F-4C02-9004-90B0AAA2B0B7 Q34744489-E2BE8250-8DB6-4631-8758-3D1C322C2CDA Q35125252-BAF48A62-25D2-4CD2-A33F-64727198D202 Q35141499-813EEF29-A2DF-4BE9-BEF5-0E7DBE71477D Q36041569-8D5D3EA0-71E2-4224-8814-99F196D63123 Q36303765-B7AFF6A0-E1B2-4AE5-A9AF-41072D1C76C3 Q36918199-B3090432-9459-4C04-8E2F-3E38B024D46D Q37069878-EDB0B5D7-F5BB-4FED-9EA3-B47830ECDFE0 Q37241740-F116AEE5-76A1-4CEC-A02F-1DEE7865A51D Q37566580-989ABCA1-C67D-4F25-ACD4-9B9FF417C4A7 Q37691651-87A6F689-BD0A-40B5-A5B6-6C3034C691D6 Q38269204-051FF617-85B4-488B-B948-743CACB3C736 Q38446353-FFDB61E9-4D88-4383-87B1-BD06721B840D Q38693888-27B67472-B592-42A9-93B5-BE4C6EC4DBA4 Q38859514-8FC6C6D4-C17B-4598-A0F1-D6A7C9505F1E Q39410475-8834C0E2-A567-43F0-8642-C90C65CF1CD8 Q41890760-3D0468D9-B6C2-4BCF-943E-1BFCA528DF07 Q42497866-A8A1899B-003B-416F-8C9A-0C6CCEFEB424 Q50172829-EB93628D-189E-4FEF-9876-D6566EF25E68 Q53068289-18DF7C1E-42D1-4F66-994D-5E8324F19A7B

P2860

Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer

http://www.wikidata.org/entity/Q33986198

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Tumor metabolism and blood flo ...... locally advanced breast cancer

@ast

Tumor metabolism and blood flo ...... locally advanced breast cancer

@en

type

label

Tumor metabolism and blood flo ...... locally advanced breast cancer

@ast

Tumor metabolism and blood flo ...... locally advanced breast cancer

@en

prefLabel

Tumor metabolism and blood flo ...... locally advanced breast cancer

@ast

Tumor metabolism and blood flo ...... locally advanced breast cancer

@en

P1433

Q33986198-6C33679E-789B-406C-BD10-A8543C65CE67

P1476

Q33986198-DBD5344D-4111-4942-9EA4-89F6962DC7C5

P2093

Q33986198-0412B1B8-89C2-4A44-8B06-B85460473D95

Q33986198-12524E94-F870-4C66-ACC5-E962EA49E9AE

Q33986198-17018C38-2565-4B9C-A3F2-04C0F86C6658

Q33986198-2342CDDA-E495-4420-BAC3-DD46E2831D05

Q33986198-5051E9C3-227B-410D-A818-97D5399D171F

Q33986198-65163B71-EF66-40F2-97AB-51B863B7F73E

Q33986198-7E3D85EB-8684-46A5-B933-15E7CB7F152D

Q33986198-81C4C9BA-1D92-4122-A99A-90E60C802C0E

Q33986198-95E3327E-B07E-4FE5-B279-34E11C76288C

Q33986198-BF878B44-C6B4-4E32-B6FB-9F67DD8C9AC8

P2860

Q33986198-0E3FE693-DBF0-442D-8E19-01FB00FA3F83

Q33986198-17EDBE1B-AB8D-4ED4-86D1-A8C07E34404F

Q33986198-1CEEC270-4C14-4A57-AB70-74A971E87556

Q33986198-31E68237-DAF3-48CE-9B06-3A397DB1B8CB

Q33986198-3220A3F3-7765-4DA8-BA78-8C72DBC80615

Q33986198-3A589D05-CDC6-47DE-9D3B-1EF1AB9856CF

Q33986198-4385DA19-C8C2-4210-850C-AD34209CC05F

Q33986198-438681D1-3701-4562-A143-268402171A1F

Q33986198-45DC0712-D9FA-46A8-8375-E7F869023BFB

Q33986198-4924EADE-63EF-4566-8063-AA5220AA16CB

P304

Q33986198-27E05C2E-954B-4801-9995-23A2A3374094

P31

Q33986198-F3CA3FF7-A96F-41CC-A542-B7B76E3A6481

P356

Q33986198-A8A7F310-B105-4C63-B2D5-96CEA1EDF0FA

P407

Q33986198-A9E43B73-F088-44A2-8878-4F0FF091D294

P433

Q33986198-E2972B12-A4AF-4B7F-8E17-F7548B428125

P478

Q33986198-1D76548D-331D-4203-8774-FD6DE3DB3078

P577

Q33986198-8D8AF16D-AEE2-4D4B-95A0-F90C39E92A16

P5875

Q33986198-A4C81418-258E-452D-852C-151812D88E81

P698

Q33986198-9A47A44B-B8B9-44E6-A6AE-26116F900041

P932

Q33986198-132D0889-A9EE-428E-8539-7445C8E92C81

P356

1078-0432.CCR-10-0026

P1433

Clinical Cancer Research

P1476

Tumor metabolism and blood flo ...... locally advanced breast cancer

@en

P2093

Brenda F Kurland

http://www.w3.org/2001/XMLSchema#string

David A Mankoff

http://www.w3.org/2001/XMLSchema#string

Erin K Schubert

http://www.w3.org/2001/XMLSchema#string

Georgina K Ellis

http://www.w3.org/2001/XMLSchema#string

Hannah M Linden

http://www.w3.org/2001/XMLSchema#string

Jennifer M Specht

http://www.w3.org/2001/XMLSchema#string

Julie R Gralow

http://www.w3.org/2001/XMLSchema#string

Kimberly H Allison

http://www.w3.org/2001/XMLSchema#string

Lisa K Dunnwald

http://www.w3.org/2001/XMLSchema#string

Robert B Livingston

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method

Supervised risk predictor of breast cancer based on intrinsic subtypes

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.

PET contributions to understanding normal and abnormal cardiac perfusion and metabolism.

Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0

P304

2803-2810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-0026

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44590211

http://www.w3.org/2001/XMLSchema#string

P698

20460489

http://www.w3.org/2001/XMLSchema#string

P932

2902373

http://www.w3.org/2001/XMLSchema#string